Strontium ranelate: A new treatment for postmenopausal osteoporosis with a dual mode of action.
- Published in:
- Current Osteoporosis Reports, 2005, v. 3, n. 1, p. 30, doi. 10.1007/s11914-005-0025-7
- By:
- Publication type:
- Article
Works matching IS 15441873 AND DT 2005 AND VI 3 AND IP 1
Results: 6
1
2
Glucocorticoid-induced osteoporosis: Treatment options and guidelines.
- Published in:
- Current Osteoporosis Reports, 2005, v. 3, n. 1, p. 25, doi. 10.1007/s11914-005-0024-8
- By:
- Publication type:
- Article
3
Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size.
- Published in:
- Current Osteoporosis Reports, 2005, v. 3, n. 1, p. 19, doi. 10.1007/s11914-005-0023-9
- By:
- Publication type:
- Article
4
Treatment of low bone mass in premenopausal women: When may it be appropriate?
- Published in:
- Current Osteoporosis Reports, 2005, v. 3, n. 1, p. 13, doi. 10.1007/s11914-005-0022-x
- By:
- Publication type:
- Article
5
Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
- Published in:
- Current Osteoporosis Reports, 2005, v. 3, n. 1, p. 5, doi. 10.1007/s11914-005-0021-y
- By:
- Publication type:
- Article
6
Web Alert.
- Published in:
- Current Osteoporosis Reports, 2005, v. 3, n. 1, p. 1, doi. 10.1007/s11914-005-0020-z
- Publication type:
- Article